however, bentley also warned that these treatments can be hazardous as they may cause bleeding which becomes more likely as the amount of svd increases.
.
.
. "the importance of our new method is that it allows for precise and automated measurement of the disease," bentley added in the study published in the journal radiology.
.
.
december 2012 (18)
.
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.